Tempus AI, Inc. (NASDAQ:TEM) Receives Average Recommendation of “Hold” from Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM) have been assigned an average recommendation of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $68.5385.

Several analysts recently commented on TEM shares. Wall Street Zen lowered Tempus AI from a “hold” rating to a “sell” rating in a research note on Saturday. HC Wainwright dropped their price objective on Tempus AI from $95.00 to $64.00 and set a “buy” rating for the company in a research note on Monday, May 11th. Needham & Company LLC reissued a “buy” rating and set a $75.00 price objective on shares of Tempus AI in a report on Monday, June 1st. BTIG Research restated a “buy” rating and issued a $80.00 target price on shares of Tempus AI in a research note on Monday, June 1st. Finally, Wolfe Research began coverage on shares of Tempus AI in a report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock.

Insider Activity

In other Tempus AI news, CEO Eric P. Lefkofsky sold 166,250 shares of the business’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $46.70, for a total value of $7,763,875.00. Following the transaction, the chief executive officer directly owned 8,808,533 shares in the company, valued at $411,358,491.10. The trade was a 1.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO James William Rogers sold 11,529 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $55.00, for a total transaction of $634,095.00. Following the completion of the transaction, the chief financial officer owned 114,866 shares in the company, valued at approximately $6,317,630. This trade represents a 9.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 572,759 shares of company stock worth $29,238,424 over the last ninety days. Corporate insiders own 24.26% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of TEM. Victory Capital Management Inc. increased its holdings in Tempus AI by 1.5% during the 3rd quarter. Victory Capital Management Inc. now owns 11,078 shares of the company’s stock valued at $894,000 after purchasing an additional 162 shares in the last quarter. US Bancorp DE boosted its stake in Tempus AI by 6.6% in the third quarter. US Bancorp DE now owns 2,848 shares of the company’s stock worth $230,000 after purchasing an additional 176 shares in the last quarter. Legacy Bridge LLC boosted its stake in Tempus AI by 1.6% in the fourth quarter. Legacy Bridge LLC now owns 12,418 shares of the company’s stock worth $733,000 after purchasing an additional 193 shares in the last quarter. Truist Financial Corp grew its holdings in shares of Tempus AI by 5.8% during the fourth quarter. Truist Financial Corp now owns 3,532 shares of the company’s stock worth $209,000 after purchasing an additional 194 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its holdings in shares of Tempus AI by 3.5% during the fourth quarter. Farther Finance Advisors LLC now owns 6,390 shares of the company’s stock worth $377,000 after purchasing an additional 219 shares during the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Price Performance

NASDAQ TEM opened at $60.27 on Friday. The company has a current ratio of 3.31, a quick ratio of 3.15 and a debt-to-equity ratio of 2.96. The stock’s 50 day moving average is $50.48 and its two-hundred day moving average is $54.57. The company has a market capitalization of $10.82 billion, a price-to-earnings ratio of -35.04 and a beta of 3.46. Tempus AI has a 1-year low of $41.73 and a 1-year high of $104.32.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.08. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The company had revenue of $348.12 million for the quarter, compared to analyst estimates of $345.44 million. During the same period in the prior year, the company posted ($0.24) EPS. The company’s revenue was up 36.1% compared to the same quarter last year. Equities analysts forecast that Tempus AI will post -1.35 earnings per share for the current fiscal year.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.